MANNATECH, INCORPORATED000105635812/31Non-accelerated FilerTRUEFALSE10-Q9/30/20242024Q3FALSE1,884,814FALSETRUEFALSE1,3641,2780.010.011,000,0001,000,000————0.00010.000199,000,00099,000,0002,742,8572,742,8571,884,8141,860,154858,043882,703P2YP3YP10YP5Y4.404.5069.6070.204.54.5SUBSEQUENT EVENTS0.4xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesmtex:regionxbrli:pureutr:Ratemtex:country00010563582024-01-012024-09-3000010563582024-10-3100010563582024-09-3000010563582023-12-3100010563582024-07-012024-09-3000010563582023-07-012023-09-3000010563582023-01-012023-09-300001056358us-gaap:CommonStockMember2023-12-310001056358us-gaap:AdditionalPaidInCapitalMember2023-12-310001056358us-gaap:RetainedEarningsMember2023-12-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001056358us-gaap:TreasuryStockCommonMember2023-12-310001056358us-gaap:RetainedEarningsMember2024-01-012024-03-3100010563582024-01-012024-03-310001056358us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001056358us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-3100010563582024-03-310001056358us-gaap:CommonStockMember2024-03-310001056358us-gaap:AdditionalPaidInCapitalMember2024-03-310001056358us-gaap:RetainedEarningsMember2024-03-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001056358us-gaap:TreasuryStockCommonMember2024-03-310001056358us-gaap:RetainedEarningsMember2024-04-012024-06-3000010563582024-04-012024-06-300001056358us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-3000010563582024-06-300001056358us-gaap:CommonStockMember2024-06-300001056358us-gaap:AdditionalPaidInCapitalMember2024-06-300001056358us-gaap:RetainedEarningsMember2024-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001056358us-gaap:TreasuryStockCommonMember2024-06-300001056358us-gaap:RetainedEarningsMember2024-07-012024-09-300001056358us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001056358us-gaap:CommonStockMember2024-09-300001056358us-gaap:AdditionalPaidInCapitalMember2024-09-300001056358us-gaap:RetainedEarningsMember2024-09-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001056358us-gaap:TreasuryStockCommonMember2024-09-3000010563582022-12-310001056358us-gaap:CommonStockMember2022-12-310001056358us-gaap:AdditionalPaidInCapitalMember2022-12-310001056358us-gaap:RetainedEarningsMember2022-12-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001056358us-gaap:TreasuryStockCommonMember2022-12-310001056358us-gaap:RetainedEarningsMember2023-01-012023-03-3100010563582023-01-012023-03-310001056358us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001056358us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-3100010563582023-03-310001056358us-gaap:CommonStockMember2023-03-310001056358us-gaap:AdditionalPaidInCapitalMember2023-03-310001056358us-gaap:RetainedEarningsMember2023-03-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001056358us-gaap:TreasuryStockCommonMember2023-03-310001056358us-gaap:RetainedEarningsMember2023-04-012023-06-3000010563582023-04-012023-06-300001056358us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001056358us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-3000010563582023-06-300001056358us-gaap:CommonStockMember2023-06-300001056358us-gaap:AdditionalPaidInCapitalMember2023-06-300001056358us-gaap:RetainedEarningsMember2023-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001056358us-gaap:TreasuryStockCommonMember2023-06-300001056358us-gaap:RetainedEarningsMember2023-07-012023-09-300001056358us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001056358us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-3000010563582023-09-300001056358us-gaap:CommonStockMember2023-09-300001056358us-gaap:AdditionalPaidInCapitalMember2023-09-300001056358us-gaap:RetainedEarningsMember2023-09-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001056358us-gaap:TreasuryStockCommonMember2023-09-300001056358country:KR2024-09-300001056358country:KR2023-12-310001056358us-gaap:SalesReturnsAndAllowancesMember2023-12-310001056358us-gaap:SalesReturnsAndAllowancesMember2024-01-012024-09-300001056358us-gaap:SalesReturnsAndAllowancesMember2024-09-3000010563582017-04-170001056358srt:MinimumMember2024-01-012024-09-300001056358srt:MaximumMember2024-01-012024-09-300001056358us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001056358mtex:IncentiveStockOptionsMember2024-01-012024-09-3000010563582024-06-012024-06-3000010563582024-07-012024-07-310001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2024-07-012024-09-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2023-07-012023-09-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2024-01-012024-09-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2023-01-012023-09-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2024-09-300001056358us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001056358us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001056358us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300001056358us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001056358us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001056358us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300001056358us-gaap:OtherAssetsMember2024-09-300001056358mtex:PropertyandEquipmentnetMember2024-09-300001056358us-gaap:OtherAssetsMember2023-12-310001056358mtex:PropertyandEquipmentnetMember2023-12-310001056358mtex:AccruedExpensesMember2024-09-300001056358mtex:AccruedExpensesMember2023-12-310001056358mtex:CurrentportionofcapitalleasesMember2024-09-300001056358mtex:CurrentportionofcapitalleasesMember2023-12-310001056358mtex:OtherlongtermliabilitiesMember2024-09-300001056358mtex:OtherlongtermliabilitiesMember2023-12-310001056358us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001056358us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001056358us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001056358us-gaap:FairValueMeasurementsRecurringMember2024-09-300001056358us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001056358us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001056358us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001056358us-gaap:FairValueMeasurementsRecurringMember2023-12-310001056358srt:AmericasMember2024-07-012024-09-300001056358srt:AmericasMember2023-07-012023-09-300001056358srt:AmericasMember2024-01-012024-09-300001056358srt:AmericasMember2023-01-012023-09-300001056358srt:AsiaPacificMember2024-07-012024-09-300001056358srt:AsiaPacificMember2023-07-012023-09-300001056358srt:AsiaPacificMember2024-01-012024-09-300001056358srt:AsiaPacificMember2023-01-012023-09-300001056358us-gaap:EMEAMember2024-07-012024-09-300001056358us-gaap:EMEAMember2023-07-012023-09-300001056358us-gaap:EMEAMember2024-01-012024-09-300001056358us-gaap:EMEAMember2023-01-012023-09-300001056358mtex:ConsolidatedProductSalesMember2024-07-012024-09-300001056358mtex:ConsolidatedProductSalesMember2023-07-012023-09-300001056358mtex:ConsolidatedProductSalesMember2024-01-012024-09-300001056358mtex:ConsolidatedProductSalesMember2023-01-012023-09-300001056358mtex:ConsolidatedPackSalesMember2024-07-012024-09-300001056358mtex:ConsolidatedPackSalesMember2023-07-012023-09-300001056358mtex:ConsolidatedPackSalesMember2024-01-012024-09-300001056358mtex:ConsolidatedPackSalesMember2023-01-012023-09-300001056358mtex:ConsolidatedOtherIncludingFreightMember2024-07-012024-09-300001056358mtex:ConsolidatedOtherIncludingFreightMember2023-07-012023-09-300001056358mtex:ConsolidatedOtherIncludingFreightMember2024-01-012024-09-300001056358mtex:ConsolidatedOtherIncludingFreightMember2023-01-012023-09-300001056358srt:AmericasMembersrt:ReportableGeographicalComponentsMember2024-09-300001056358srt:AmericasMembersrt:ReportableGeographicalComponentsMember2023-12-310001056358srt:AsiaPacificMembersrt:ReportableGeographicalComponentsMember2024-09-300001056358srt:AsiaPacificMembersrt:ReportableGeographicalComponentsMember2023-12-310001056358us-gaap:EMEAMembersrt:ReportableGeographicalComponentsMember2024-09-300001056358us-gaap:EMEAMembersrt:ReportableGeographicalComponentsMember2023-12-31



美國
證券交易委員會
華盛頓特區20549
表單 10-Q
（標記一）
x    根據1934年證券交易法第13或15(d)節的季度報告
截至2024年9月30日季度結束：
或者
§    根據1934年《證券交易法》第13或15（d）條提交的過渡報告
在從___________到___________的過渡期間。
委員會文件號。 000-24657
寰泰生技股份有限公司
（依據其憲章指定的註冊名稱）
德克薩斯州 75-2508900
（成立或組織的州或其他轄區） （納稅人識別號碼）
1410湖邊公園大道，200號套房，
Flower Mound,德克薩斯州 75028
(主要領導機構的地址) (郵政編碼)
註冊人的電話號碼，包括區號：(972) 471-7400
根據法案第12(b)條註冊的證券：
每一類的名稱交易標誌在其上註冊的交易所的名稱
普通股,每股面值$0.0001交易所納斯達克股票交易所有限責任公司
請勾選以下選項以指示註冊人是否在過去12個月內(或在註冊人需要提交此類報告的較短時間內)已提交證券交易法1934年第13或15(d)條所要求提交的所有報告，並且在過去90天內已受到此類報告提交要求的影響。是的 x No o

請在以下勾選方框表示註冊人是否已在Regulation S-T Rule 405規定的前12個月(或在註冊人需要提交此類文件的較短期間內)提交了每個互動數據文件。是的 x無 o

請用複選標記表示，公司是否爲大型快速申報提交者、快速申報提交者、非快速申報提交者、較小報告公司或新興成長型公司。請參閱《交易所法》第120億2條中「快速申報提交者」、「大型快速申報提交者」、「較小報告公司」和「新興成長型公司」的定義。
大型加速報告人
 ¨
加速文件提交人
 ¨
非加速文件提交人x較小的報告公司x新興成長公司
 ¨
如果是新興成長型公司，則在選中複選標記的情況下，表明註冊人選擇不使用交易所法第13(a)條規定的任何新的或修訂後的財務會計準則遵守的延期過渡期。 o

請在複選標誌處註明公司是否爲殼公司（根據交易所法令第12b-2條的定義）。
是的 o No x

截至2024年10月31日，註冊人唯一類普通股的流通股數爲每股面值0.0001美元。 1,884,814.


寰泰生技股份有限公司
目錄
第I部分 - 財務信息 
  
  
  
  
第二部分 - 其他信息 
  
  
  
  
  
  
  


關於前瞻性聲明的特別說明

本表格10-Q中的某些披露和分析，包括引用的信息，可能包含根據1933年證券法第27A節（「證券法」）、1934年證券交易法第21E節（「交易所法」）及1995年私人證券訴訟改革法的定義的前瞻性陳述，這些陳述面臨各種風險和不確定性。觀點、預測、預計、指導或其他非歷史事實的陳述被視爲前瞻性陳述，僅反映當前對未來事件和財務表現的看法。這些前瞻性陳述中的一些包括關於：
•管理層對未來運營的計劃和目標；
•現有現金流足以支持未來的運營需求;
•與預算、未來資本需求、市場份額增長以及預計的資本項目和義務相關的未來計劃;
•淨遞延稅資產的實現；
•有能力削減營業支出；
•全球法定稅率保持不變；
•未來市場變化對外幣匯率轉換的影響;
•某些政策、程序和內部流程可能有助於降低市場風險的暴露；
•新會計公告對財務控件、運營結果或現金流的影響；
•新案件或現有訴訟事項的結果；
•新或現有監管調查或審查的結果；以及
•本報告中描述的其他假設是這些前瞻性聲明的基礎。

儘管我們相信這些前瞻性陳述中的預期是合理的，但這些前瞻性陳述受制於某些事件、風險、假設和不確定性，包括下述討論的內容，以及我們2023年12月31日截止年度的Form 10-K中「風險因素」部分和本Form 10-Q及本處引用的文件。 如果這些風險或不確定性中的一項或多項實際發生，或者我們的基本假設被證明是錯誤的，實際結果和發展可能會與這些前瞻性陳述中表達或暗示的內容大相徑庭。 例如，以下任何因素都可能導致實際結果與我們的預測大相徑庭：
•營養補充品行業的整體增長或缺乏增長；
•預計未來產品開發計劃;
•製造業成本的變化;
•包裝和產品組合的變化;
•任何對全球貨幣關聯職業、薪酬計劃或激勵措施，以及管理這些計劃和激勵措施的法規變更的未來影響；
•吸引和留住獨立合作伙伴和優先客戶的能力；
•新的監管變化可能會影響運營、產品或補償計劃和激勵措施；
•我們外部供應商和製造商的能力，能夠在足夠的數量上供應產品並遵守
我們的產品安全和質量標準或適用法律;
•我們在產品和定價方面的業務競爭性質；
•publicity related to our products or network marketing; and
•the political, social and economic climate of the countries in which we operate.

Forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “hopes,” “potential,” and “continues” or other similar words or the negative of such terms and other comparable terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Readers are cautioned when considering these forward-looking statements to keep in mind these risks, assumptions, and uncertainties and any other cautionary statements in this report, as all of the forward-looking statements contained herein speak only as of the date of this report.

Unless stated otherwise, all financial information throughout this report and in the Condensed Consolidated Financial Statements and related Notes include Mannatech, Incorporated and all of its subsidiaries on a consolidated basis and may be referred to herein as “Mannatech,” “the Company,” “its,” “we,” “us,” “our,” or “their.”

Our products are not intended to diagnose, cure, treat, or prevent any disease, and any statements about our products contained in this report have not been evaluated by the Food and Drug Administration, also referred to herein as the “FDA”.
1

 PART I – FINANCIAL INFORMATION

Item 1. Financial Statements
MANNATECH, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS – (UNAUDITED)
(in thousands, except share and per share amounts)
ASSETSSeptember 30, 2024 (unaudited)December 31, 2023
Cash and cash equivalents$12,150 $7,731 
Restricted cash939 938 
Accounts receivable, net of allowance of $932 and $1,278 22 91 
Income tax receivable414 465 
Inventories, net11,660 14,535 
Prepaid expenses and other current assets2,291 1,774 
Deferred commissions1,224 2,130 
Total current assets28,700 27,664 
Property and equipment, net3,118 4,147 
Operating lease right-of-use assets2,532 3,315 
Other assets3,674 3,751 
Deferred tax assets, net1,913 1,611 
Long-term restricted cash635 718 
Total assets$40,572 $41,206 
LIABILITIES AND SHAREHOLDERS’ EQUITY  
Commissions and incentives payable$8,203 $8,175 
Accrued expenses4,803 5,118 
Deferred revenue3,018 4,786 
Accounts payable3,580 4,010 
Current portion of operating lease liabilities1,508 1,661 
Taxes payable1,361 1,521 
Current notes payable208 240 
Current portion of finance lease liabilities271 269 
Total current liabilities22,952 25,780 
Long-term notes payable3,600 — 
Operating lease liabilities, excluding current portion1,787 2,582 
Other long-term liabilities1,483 1,404 
Finance lease liabilities, excluding current portion751 956 
Total liabilities30,573 30,722 
Commitments and contingencies
Shareholders’ equity:  
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding— — 
Common stock, $0.0001 par value, 99,000,000 shares authorized, 2,742,857 shares issued and 1,884,814 shares outstanding as of September 30, 2024 and 2,742,857 shares issued and 1,860,154 shares outstanding as of December 31, 2023
— — 
Additional paid-in capital33,005 33,309 
Accumulated deficit(1,073)(1,301)
Accumulated other comprehensive loss(1,997)(1,015)
Treasury stock, at average cost, 858,043 shares as of September 30, 2024 and 882,703 shares as of December 31, 2023
(19,936)(20,509)
Total shareholders’ equity9,999 10,484 
Total liabilities and shareholders’ equity$40,572 $41,206 
2

MANNATECH, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS – (UNAUDITED)
(in thousands, except per share information)
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net sales$31,725 $32,553 $88,858 $99,261 
Cost of sales8,105 6,625 20,763 21,042 
Gross profit23,620 25,928 68,095 78,219 
Operating expenses:  
Commissions and incentives12,893 13,178 36,237 40,200 
Selling and administrative expenses9,840 12,578 31,293 38,088 
Total operating expenses22,733 25,756 67,530 78,288 
Income (loss) from operations887 172 565 (69)
Interest expense, net(109)(17)(196)(3)
Other (expense) income, net(1,495)320 495 803 
(Loss) income before income taxes(717)475 864 731 
Income tax benefit (expense)389 (457)(636)(1,214)
Net (loss) income$(328)$18 $228 $(483)
(Loss) income per common share:  
Basic$(0.17)$0.01 $0.12 $(0.26)
Diluted$(0.17)$0.01 $0.12 $(0.26)
Weighted-average common shares outstanding:  
Basic1,885 1,863 1,885 1,868 
Diluted1,885 1,863 1,885 1,868 


MANNATECH, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS – (UNAUDITED)
(in thousands)
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net (loss) income$(328)$18 $228 $(483)
Foreign currency translations2,105 (889)(982)(2,339)
Comprehensive income (loss)$1,777 $(871)$(754)$(2,822)
 
See accompanying notes to unaudited condensed consolidated financial statements.
3

MANNATECH, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY – (UNAUDITED)
(amounts in thousands, except share data)
Common Stock, $0.0001 par value
 Number of SharesAmountAdditional
paid-in
capital		Accumulated deficitAccumulated
other
comprehensive
loss		Treasury
stock		Total
shareholders’
equity
Balance at January 1, 20241,860,154 $— $33,309 $(1,301)$(1,015)$(20,509)$10,484 
Net income— — — 1,180 — — 1,180 
Charge related to stock-based compensation— — 12 — — — 12 
Issuance of unrestricted shares24,660 — (373)— — 573 200 
Foreign currency translations— — — — (1,431)— (1,431)
Balance at March 31, 20241,884,814 $— $32,948 $(121)$(2,446)$(19,936)$10,445 
Net loss— — — (624)— — (624)
Charge related to stock-based compensation— — 34 — — — 34 
Foreign currency translations— — — — (1,656)— (1,656)
Balance at June 30, 20241,884,814 $— $32,982 $(745)$(4,102)$(19,936)$8,199 
Net loss— — — (328)— — (328)
Charge related to stock-based compensation— — 23 — — — 23 
Foreign currency translations— — — — 2,105 — 2,105 
Balance at September 30, 20241,884,814 $— $33,005 $(1,073)$(1,997)$(19,936)$9,999 

4

Common Stock, $0.0001 par value
Number of SharesAmountAdditional
paid-in
capital		Retained earningsAccumulated
other
comprehensive
loss		Treasury
stock		Total
shareholders’
equity
Balance at January 1, 20231,858,800 $— $33,377 $1,686 $(208)$(20,679)$14,176 
Net income— — — 604 — — 604 
Payment of cash dividends— — — (375)— — (375)
Charge related to stock-based compensation— — 11 — — — 11 
Issuance of unrestricted shares12,808 — (76)— — 299 223 
Stock option exercises2,000 — (35)— — 47 12 
Foreign currency translations— — — — (799)— (799)
Balance at March 31, 20231,873,608 $— $33,277 $1,915 $(1,007)$(20,333)$13,852 
Net loss— — — (1,105)— — (1,105)
Payment of cash dividends— — — (373)— — (373)
Charge related to stock-based compensation— — 17 — — — 17 
Repurchase of common stock(7,396)— — — — (98)(98)
Foreign currency translations— — — — (651)— (651)
Balance at June 30, 20231,866,212 $— $33,294 $437 $(1,658)$(20,431)$11,642 
Net income— — — 18 — — 18 
Charge related to stock-based compensation— — 7 — — — 7 
Repurchase of common stock(6,058)— — — — (78)(78)
Foreign currency translations— — — — (889)— (889)
Balance at September 30, 20231,860,154 $— $33,301 $455 $(2,547)$(20,509)$10,700 

See accompanying notes to unaudited condensed consolidated financial statements.
5

MANNATECH, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS – (UNAUDITED)
(in thousands)
 Nine Months Ended
September 30,
 20242023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)$228 $(483)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:  
Depreciation and amortization1,174 1,224 
Non-cash operating lease expense1,228 1,232 
Provision for inventory losses661 279 
Provision for (reversal of) allowance for credit losses(319)345 
Loss on retirement of property and equipment253 7 
Gain on disposal of subsidiary entity(226)— 
Unrealized gain from foreign exchange(146)— 
Charge related to stock-based compensation269 259 
Deferred income taxes(302)303 
Changes in operating assets and liabilities:  
Accounts receivable388 (276)
Income tax receivable51 5 
Inventories2,214 (885)
Prepaid expenses and other current assets1,769 946 
Deferred commissions906 697 
Other assets(9)213 
Accounts payable(430)(482)
Accrued expenses(827)(247)
Other long-term liabilities(2,503)(854)
Taxes payable(159)(1,970)
Commissions and incentives payable28 (205)
Deferred revenue(1,768)(1,157)
Net cash provided by (used in) operating activities2,480 (1,049)
CASH FLOWS FROM INVESTING ACTIVITIES:  
Acquisition of property and equipment(403)(540)
Cash used in investing activities(403)(539)
CASH FLOWS FROM FINANCING ACTIVITIES:  
Proceeds from stock options exercised— 12 
Repurchase of common stock— (176)
Payment of cash dividends— (748)
Proceeds from notes payable3,600 — 
Repayment of finance lease obligations and other long-term liabilities(734)(717)
Net cash provided by (used in) financing activities2,866 (1,629)
Effect of currency exchange rate changes on cash and cash equivalents(606)(2,293)
Net increase (decrease) in cash, cash equivalents, and restricted cash4,337 (5,510)
Cash, cash equivalents, and restricted cash at the beginning of the period9,387 15,197 
Cash, cash equivalents, and restricted cash at the end of the period$13,724 $9,687 
    
See accompanying notes to unaudited condensed consolidated financial statements.

6


Nine Months Ended
September 30,
20242023
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:  
Income taxes paid$812 $2,511 
Interest paid on finance leases and other financing arrangements$323 $72 
NON-CASH INVESTING AND FINANCING ACTIVITIES
Assets acquired through other financing arrangements$446 $597 
Operating lease right-of-use assets acquired in exchange for new operating lease liabilities$359 $284 
Finance lease right-of-use assets acquired in exchange for new finance lease liabilities$— $1,305 

See accompanying notes to unaudited condensed consolidated financial statements.



7
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS




NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Mannatech, Incorporated (together with its subsidiaries, the “Company”), located in Flower Mound, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the Nasdaq Global Select Market under the symbol “MTEX.” The Company develops, markets, and sells high-quality, proprietary nutritional supplements, skin care and anti-aging products, and weight-management products. We currently sell our products into three regions: (i) the Americas (the United States, Canada and Mexico); (ii) EMEA (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); and (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Thailand, Hong Kong, Taiwan and China). During the second quarter of 2024 the Company liquidated its entity in Sweden, Mannatech Sverige AB.
The Company sells its products principally through network marketing distribution channels via its active associates (“independent associate” or “associates” or “distributors”) and its “preferred customers,” Active business building associates and preferred customers purchase the Company’s products at published wholesale prices. The Company cannot distinguish products sold for personal use from other sales, when sold to associates, because it is not involved with the products after delivery, other than usual and customary product warranties and returns. Only associates are eligible to earn commissions and incentives. We also ship our products to customers in the following countries: Belgium, France, Greece, Italy, Luxembourg, and Poland. The Company operates a non-direct selling business in mainland China. Our subsidiary in China, Meitai Daily Necessity & Health Products Co., Ltd. (“Meitai”), is operating as a traditional retailer under a cross-border e-commerce model in China. Meitai cannot legally conduct a direct selling business in China unless it acquires a direct selling license in China.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with instructions for Form 10-Q and Article 8-03 of Regulation S-X. Accordingly, the Company’s condensed consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by GAAP to be considered “complete financial statements”. However, in the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company’s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2023 consolidated balance sheet was included in the audited consolidated financial statements in the Company’s annual report on Form 10-K for the year ended December 31, 2023 and filed with the United States Securities and Exchange Commission (the “SEC”) on March 28, 2024 (the “2023 Annual Report”), which includes all disclosures required by GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2023 Annual Report.

Principles of Consolidation
The condensed consolidated financial statements and footnotes include the accounts of Mannatech and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates
The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.
The use of estimates is pervasive throughout the condensed consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the condensed consolidated financial statements, Organization and Summary of Significant Accounting Policies.

Significant Accounting Policies
Our significant accounting policies are described in the notes to our consolidated financial statements for the year ended December 31, 2023 included in our 2023 Annual Report. There have been no significant changes in our accounting policies or the application thereof during the first, second and third quarter of 2024.



8
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Basis of Presentation
Certain prior year amounts have been reclassified on the Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations to conform to the current year presentation. These reclassifications had no effect on the previously reported results of operations.

Cash and Cash Equivalents
The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents was $12.2 million at September 30, 2024 and $7.7 million at December 31, 2023. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are received within 24 to 72 hours. At September 30, 2024 and December 31, 2023, credit card receivables were $2.0 million and $1.4 million, respectively, and cash and cash equivalents held in bank accounts in foreign countries totaled $4.8 million and $3.5 million at September 30, 2024 and December 31, 2023, respectively. The Company invests cash in liquid instruments, such as money market funds and interest-bearing deposits. The Company holds cash in high quality financial institutions and does not believe it has an excessive exposure to credit concentration risk.
A significant portion of our cash and cash equivalent balances were concentrated within the Republic of Korea, with cash and cash equivalents totaling $3.3 million and $2.3 million at September 30, 2024 and December 31, 2023, respectively. In addition, for the three and nine months ended September 30, 2024 and 2023, a concentrated portion of our operating cash flows were earned from operations within the Republic of Korea. An adverse change in economic conditions within the Republic of Korea could negatively affect the Company’s results of operations. 

Restricted Cash
The Company is required to restrict cash for: (i) direct selling insurance premiums and credit card sales in the Republic of Korea; (ii) reserves related to credit card sales in the United States and Canada; and (iii) the Australia building lease collateral. At September 30, 2024 and December 31, 2023, our total restricted cash was $1.6 million and $1.7 million, respectively.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Company's condensed consolidated balance sheets to the total amount presented in the condensed consolidated statement of cash flows (in thousands):
September 30, 2024December 31, 2023September 30, 2023December 31, 2022
Cash and cash equivalents$12,150 $7,731 $7,928 $13,777 
Current restricted cash 939 938 938 944 
Long-term restricted cash 635 718 821 476 
Cash, cash equivalents, and restricted cash $13,724 $9,387 $9,687 $15,197 

Accounts Receivable, net
Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. As of September 30, 2024 and December 31, 2023, receivables consisted primarily of amounts due from preferred customers and associates.
The Company's accounts receivable balances, net, are presented below (in thousands):
September 30, 2024December 31, 2023December 31, 2022
Accounts receivable, net
$22 $91 $218 
In accordance with ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"), the Company assesses collectability by reviewing accounts receivable on a collective basis where similar characteristics exist and on an individual basis when the Company identifies specific customers with known disputes or collectability issues. Expected loss estimates are determined utilizing an aging schedule. In determining the amount of the allowance for credit losses, the Company considers historical collectability based on past due status and makes judgments about the creditworthiness of customers based on ongoing credit evaluations. The Company also considers customer-specific information, current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss data.
9
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

At September 30, 2024 and September 30, 2023, the Company held an allowance for credit losses of $0.9 million and $1.3 million, respectively.
September 30, 2024September 30, 2023
Allowance for credit losses at beginning of period$1,278 $973 
Provision in current period(319)344 
Accounts charged off against the allowance(27)(2)
Allowance for credit losses at end of period$932 $1,315 

Inventories
Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or net realizable value. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off.

Other Assets
Other Assets consisted of the following (in thousands):
September 30, 2024December 31, 2023
Investment in Korea Mutual Aid Cooperative & Consumer$2,177 $2,204 
Deposits for building leases1,260 1,310 
Manapol Trademark237237
$3,674 $3,751 

The Company accounts for its investment in Korea Mutual Aid Cooperative & Consumer at its initial investment amount, in accordance with ASC 321, Investments - Equity Securities (“ASC 321”). This guidance offers an alternative to the requirement of carrying equity interests at fair value as per ASC 820, Fair Value Measurement. The measurement alternative is applicable to certain equity interests without readily determinable fair values that fall within the scope of ASC 321 and are otherwise required to be measured at fair value. The application of this measurement alternative is optional and is applied upon the acquisition of an equity interest. See Note 9, Fair Value, for more information.

Accrued Expenses
Accrued expenses consisted of the following (in thousands):
September 30, 2024December 31, 2023
Accrued compensation$2,100 $1,707 
Accrued legal and accounting fees931 865 
Customer deposits and sales returns410 515 
Other accrued operating expenses460 506 
Accrued shipping and handling costs346 291 
Accrued sales and other taxes188 201 
Accrued travel expenses related to corporate events197 131 
Accrued inventory purchases136 861 
Accrued royalties35 38 
Accrued rent expense— 3 
$4,803 $5,118 


10
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Other Long-Term Liabilities
Other long-term liabilities consisted of the following (in thousands). See Note 9, Employee Benefit Plans, of the Company’s 2023 Annual Report for more information.

September 30, 2024December 31, 2023
Government required severance$926 $822 
Accrued lease restoration costs365 369 
Defined benefit plan obligation192 213 
$1,483 $1,404 

Revenue Recognition
The Company’s revenue is derived from sales of individual products and associate fees or, in certain geographic markets, starter packs. Substantially all of the Company’s product sales are made at published wholesale prices to associates and preferred customers. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience. During the quarter ended September 30, 2024 the Company changed its shipping terms with customers such that ownership transfers upon delivery to the freight carrier, satisfying the Company's performance obligation. Previously, the Company's shipping terms were FOB destination, so the Company recognized revenue upon delivery of the product to the customer. As a result of the change in shipping terms, no revenue was required to be deferred for product sales that were in transit at September 30, 2024. The Company's deferred revenue balances related to product orders in transit were $0 at September 30, 2024 and $1.4 million at December 31, 2023, respectively. The Company's remaining performance obligations related to associate fees were $0.1 million at both September 30, 2024 and December 31, 2023. These amounts are included in Deferred revenue on the accompanying Condensed Consolidated Balance Sheets, respectively.
Orders placed by associates or preferred customers constitute our contracts with customers. Product sales placed in the form of an automatic order contain two performance obligations: (a) the sale of the product and (b) the loyalty program. The Company's customer loyalty program conveys a material right to the customer to redeem loyalty points for the purchase of products. For these contracts, the Company accounts for each of these obligations separately as they are each distinct. The transaction price is allocated between the product sale and the loyalty program on a relative standalone selling price basis. Sales placed through a one-time order contain only the first performance obligation noted above — the delivery of the product. Payments are made immediately through credit card upon purchase of the products.
The Company provides associates with access to a complimentary three-month package for the Success Tracker™ and Mannatech+ online business tools with the first payment of an associate fee. The first payment of an associate fee contains three performance obligations: (a) the associate fee, whereby the Company provides an associate with the right to earn commissions, bonuses and incentives for a year, (b) three months of complimentary access to utilize the Success Tracker™ online tool and (c) three months of complimentary access to utilize the Mannatech+ online business tool. The transaction price is allocated between the three performance obligations on a relative standalone selling price basis and revenue is recognized over the period that access to the tools is active. Associates do not have complimentary access to online business tools after the first contractual period.
With regard to both of the aforementioned contracts, the Company determines the standalone selling prices by using observable inputs which includes the Company’s standard published price lists.

Deferred Revenue
The Company defers certain components of its revenue. Deferred revenue consisted of: (i) sales of products shipped but not received by customers by the end of the respective period (up to the change in shipping terms with customers); (ii) revenue from the loyalty program; (iii) prepaid registration fees from customers planning to attend a future corporate-sponsored event; and (iv) prepaid annual associate fees. To defer product sales that have not been received by customers, the Company estimates order delivery dates using weighted averages of historical delivery data collected from its freight carriers.
The table below presents the changes to deferred revenue balances (in thousands).
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Total deferred revenue at beginning of the period$4,152 $4,330 $4,786 $5,106 
Amount recognized as revenue during the period$(1,836)(1,338)(4,747)(5,055)
New deferrals at the end of the period$702 957 2,979 3,898 
Total deferred revenue at end of the period$3,018 $3,949 $3,018 $3,949 
11
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS


The Company’s customer loyalty program conveys a material right to the customer as it provides the promise to redeem loyalty points for the purchase of products, which is based on earning points through placing consecutive qualified orders. The Company factors in breakage rates, which is the percentage of the loyalty points that are expected to be forfeited or expire, for purposes of revenue recognition. Breakage rates are estimated based on historical data and can be reasonably and objectively determined.
The deferred revenue associated with the loyalty program at each of September 30, 2024 and September 30, 2023 was $2.9 million.
Three Months Ended
September 30,		Nine Months Ended
September 30,
Loyalty program (in thousands)
2024202320242023
Loyalty deferred revenue at beginning of the period$2,861 $2,597 $3,242 $4,167 
Loyalty points forfeited or expired(757)(440)(2,167)(3,176)
Loyalty points used(2,227)(2,174)(6,745)(6,846)
Loyalty points vested1,624 2,042 7,171 7,880 
Loyalty points unvested1,399 867 1,399 867 
Loyalty deferred revenue at end of period$2,900 $2,892 $2,900 $2,892 

    Deferred Commissions
The Company defers commissions on (i) the sales of products shipped but not received by customers by the end of the respective period (up to the change in shipping terms with the customers) and (ii) the loyalty program. Deferred commissions are incremental costs and are charged to expense when the related revenue is recognized.
The table below illustrates the changes to deferred commission balances (in thousands).
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Deferred commissions at beginning of the period$1,910 $1,852 $2,130 $2,476 
Amount recognized as commissions expense(734)(535)(1,899)(2,022)
New commission deferrals at the end of the period48 462 993 1,325 
Total deferred commissions at end of the period$1,224 $1,779 $1,224 $1,779 

Sales Refunds and Allowances
The Company utilizes the expected value method, as set forth by Accounting Standard Codification ("ASC") Topic 606 Revenue from Contracts with Customers ("ASC 606"), to estimate the sales returns and allowance liability by taking the weighted average of the sales return rates over a rolling six-month period. The Company allocates the total amount recorded within the sales return and allowance liability as a reduction of the overall transaction price for the Company’s product sales. The Company deems the sales refund and allowance liability to be a variable consideration.
Historically, sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have historically averaged 0.5% or less of our gross sales.
As of each of the periods shown below, our sales return reserve consisted of the following (in thousands):
September 30, 2024September 30, 2023
Sales reserve at beginning of period$41 $59 
Provision in current period627 620 
Returns charged off against the reserve(606)(630)
Sales reserve at end of period$62 $49 
12
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS


Shipping and Handling Costs
The Company records inbound freight as a component of inventory and cost of sales. The Company records freight and shipping fees collected from its customers as fulfillment costs. Freight and shipping fees are accounted for as activities to fulfill the promise to transfer the products to the customer, not as a separate performance obligation.

Commissions and Incentives
Associates earn commissions and incentives based on their direct and indirect commissionable net sales over each month of the fiscal year. The Company accrues commissions and incentives when earned by associates and pays commissions on product and pack sales on a monthly basis.

Comprehensive Income (Loss) and Accumulated Other Comprehensive Income
Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income (loss) consists of the Company’s net income (loss), foreign currency translation adjustments from its Japan, Republic of Korea, Denmark, Norway, Sweden, Mexico, Taiwan and China operations, remeasurement of intercompany balances of a long-term-investment nature from its Mexico, Taiwan, and Cyprus operations, and changes in the pension obligation for its Japanese employees.

Accounting Pronouncements Issued but Not Yet Effective
In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for annual reporting periods beginning after December 15, 2023 and interim reporting periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of implementing this guidance but does not expect adoption to have a material impact on its consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 are effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of implementing this guidance on its consolidated financial statements.
Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.
NOTE 2: INVENTORIES
Inventories consist of raw materials, finished goods, and promotional materials. The Company provides an allowance for any slow-moving or obsolete inventories. The allowance for slow-moving inventory obsolescence was $0.6 million at each of September 30, 2024 and December 31, 2023.
Inventories as of September 30, 2024 and December 31, 2023, consisted of the following (in thousands):
 September 30, 2024December 31, 2023
Raw materials$5,110 $5,104 
Finished goods6,550 9,431 
Total$11,660 $14,535 

NOTE 3: INCOME TAXES
For the three and nine months ended September 30, 2024, the Company’s effective tax rate was 83.9% and 71.1%, respectively. For the three and nine months ended September 30, 2023, the Company’s effective tax rate was 43.0% and 166.1%, respectively. For the three and nine months ended September 30, 2024 and 2023, the Company's effective tax rate was determined based on the estimated annual effective income tax rate. The effective tax rate for the three and nine months ended September 30, 2024 and September 30, 2023, was different from the federal statutory rate due to the mix of earnings across jurisdictions and the associated valuation allowances recorded on losses in certain jurisdictions.

13
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4: NOTES PAYABLE
Notes payable were $3.8 million and $0.2 million as of September 30, 2024 and December 31, 2023, respectively.
The current portion was $0.2 million at each of September 30, 2024 and December 31, 2023, as a result of insurance financing arrangements. The notes are fully amortizing and payments are made monthly, according to the terms of the agreements which have a weighted average effective interest rate of 10.5%.
The long-term portion of notes payable relates to three unsecured notes, described below. The long-term portion of notes payable was $3.6 million as of September 30, 2024. There were no unsecured notes at December 31, 2023.
On April 23, 2024, the Company issued an unsecured note payable to Jade Capital in the amount of $2.5 million. The note bears interest at 16% per annum and requires quarterly interest payments beginning June 30, 2024. The note is due in full on September 30, 2026. The Company has the right to prepay all or a portion of the Promissory Note at any time without premium or penalty. Tyler Rameson is an independent member of Mannatech's Board of Directors, and is the managing member of Jade Capital. As of September 30, 2024, there was no current portion and the long-term portion of the balance was $2.5 million.
On April 23, 2024, the Company issued an unsecured note payable to J. Stanley Fredrick in the amount of $1.0 million. The note bears interest at 16% per annum and requires quarterly interest payments beginning June 30, 2024. The note is due in full on September 30, 2026. The Company has the right to prepay all or a portion of the Promissory Note at any time without premium or penalty. Mr. Fredrick is the Chairman of Mannatech's Board of Directors. As of September 30, 2024, there was no current portion and the long-term portion of the balance was $1.0 million.
On April 23, 2024, the Company issued an unsecured note payable to Kevin Robbins in the amount of $0.1 million. The note bears interest at 16% per annum and requires quarterly interest payments beginning June 30, 2024. The note is due in full on September 30, 2026. The Company has the right to prepay all or a portion of the Promissory Note at any time without premium or penalty. Mr. Robbins is a member of Mannatech's Board of Directors. As of September 30, 2024, there was no current portion and the long-term portion of the balance was $0.1 million.
As of September 30, 2024, the Company's future principal payments on notes payable were as follows (in thousands):
Principal PaymentsRemaining 202420252026ThereafterTotal
Insurance Financing Notes$124 $84 $— $— $208 
Jade Capital Note— — 2,500 — 2,500 
J.S. Fredrick Note— — 1,000 — 1,000 
K. Robbins Note— — 100 — 100 
Total$124 $84 $3,600 $— $3,808 

NOTE 5: STOCK-BASED COMPENSATION
Stock Option Plan
The Company currently has one active stock-based compensation plan, the Mannatech, Incorporated 2017 Stock Incentive Plan, which was adopted by the Company’s Board of Directors (the "Board") on April 17, 2017 and was approved by its shareholders on June 8, 2017, and subsequently amended by the Board in February 2019, which amendment was approved by the Company's shareholders on June 11, 2019 (as amended, the "2017 Plan"). The Board has reserved a maximum of 370,000 shares of our common stock that may be issued under the 2017 Plan (subject to adjustments for stock splits, stock dividends or other changes in corporate capitalization). As of September 30, 2024, the Company had a total of 121,971 shares available for grant under the 2017 Plan, which expires on April 16, 2027.
The 2017 Plan provides for grants of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance stock and performance stock units to our employees, board members, and consultants. However, only employees of the Company and its corporate subsidiaries are eligible to receive incentive stock options. The exercise price per share for all stock options will be no less than the market value of a share of common stock on the date of grant. Any incentive stock option granted to an employee owning more than 10% of our common stock will have an exercise price of no less than 110% of our common stock’s market value on the grant date.
The majority of stock options vest over two or three years, and generally are granted with a term of ten years, or five years in the case of an incentive option granted to an employee who owns more than 10% of our common stock.
The Company is required to measure and recognize compensation expense related to any outstanding and unvested stock options in its consolidated financial statements using a fair-value based option-pricing model. The Company records stock-based compensation expense related to granting stock options in selling and administrative expenses. The fair value of the stock option award is calculated using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model
14
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

requires us to apply judgment and use subjective assumptions about expected dividend yields, risk-free interest rates, price volatility related to the underlying shares, and the expected stock option life, including forfeitures.

The following assumptions were used to calculate the fair value of stock options granted:

June 2024 GrantJuly 2024 Grant
Estimated fair value per share of options granted:$4.67 $4.00 
Assumptions:
Annualized dividend yield— %— %
Risk-free rate of return4.4 %4.5 %
Common stock price volatility69.6 %70.2 %
Expected average life of stock options (in years)4.54.5

The computation of the expected volatility assumption used in the Black-Scholes calculations for new grants is based on historical volatility of the Company’s stock. The expected life assumptions are based on the Company’s historical employee exercise and forfeiture behavior.

During the nine months ended September 30, 2024 and 2023, the Company granted 14,500 and 5,000 stock options, respectively. The weighted average fair value of stock options granted during the nine months ended September 30, 2024 and 2023 was approximately $4.47 and $4.32 per share, respectively.

Stock Grants
On March 11, 2024, the Company issued a grant of 8,187 restricted stock units of our common stock to our Chief Executive Officer. Under the terms of the stock grant, the grant is available for 18 months and will not vest until Mannatech's stock price averages $15.00 per share (i.e., the volume weighted price) for 60 consecutive days. If the contingency is not met within the 18-month period, the grant will lapse and will not be awarded.
The Company is required to measure and recognize compensation expense related to the grant in its consolidated financial statements using a fair-value based model. The Company has determined the fair value of the grant is $0.1 million. Accordingly, the company has recognized compensation expense related to the grant of $10 thousand and $23 thousand for the three and nine months ended September 30, 2024, respectively.
The Company recognized compensation expense as follows for the three and nine months ended September 30 (in thousands):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Total gross compensation expense$23 $8 $69 $36 
Total tax benefit associated with compensation expense3 2 11 8 
Total net compensation expense$20 $6 $58 $28 

As of September 30, 2024, the Company expects to record compensation expense in the future as follows (in thousands):
Three months
ending
December 31,
2024		Years ending December 31,
 20252026
Total gross unrecognized compensation expense$17 $51 $— 

Equity-Based Compensation to Directors
At the discretion of the Board, each director may receive a portion of their fees payable in stock grants in lieu of cash compensation. For the nine months ending September 30, 2024 and 2023, the Company issued a total of 24,660 and 12,808 treasury stock to the members of the Board as a part of their compensation, respectively. The stock grants to the Board were vested upon grant and the Company recognized $0.2 million compensation expense for each of the nine months ending September 30, 2024 and 2023.
15
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6: SHAREHOLDERS’ EQUITY
Treasury Stock
There were no shares repurchased during the three and nine months ended September 30, 2024. During the three and nine months ended September 30, 2023, the Company repurchased 6,058 and 13,454 shares of its outstanding common stock, respectively.
As of September 30, 2024 and December 31, 2023, the Company had 858,043 and 882,703 treasury shares, respectively.

Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss displayed in the Condensed Consolidated Statement of Shareholders’ Equity represents the results of certain shareholders’ equity changes not reflected in the Condensed Consolidated Statements of Operations, such as foreign currency translation and certain pension and post-retirement benefit obligations.
The after-tax components of accumulated other comprehensive loss are as follows (in thousands):
 Foreign
Currency
Translation		Pension
Postretirement
Benefit
Obligation		Accumulated
Other
Comprehensive
Loss, Net
Balance as of December 31, 2023$(1,427)$412 $(1,015)
Current-period change (1)
(982)— (982)
Balance as of September 30, 2024$(2,409)$412 $(1,997)
(1) No material amounts were reclassified from accumulated other comprehensive loss.

Dividends
Holders of Common Stock are entitled to receive dividends at the same rate, when, as and if declared by our Board of Directors out of funds legally available therefor, subject to any statutory or contractual restrictions on the payment of dividends and to the rights of the holders of one or more outstanding series of our preferred stock. For the three and nine months ended September 30, 2024, the Company did not pay any dividends. During the nine months ended September 30, 2023, the Company paid dividends of $0.20 per share to holders of our Common Stock in the amount of $0.7 million.


NOTE 7: LITIGATION

Litigation in General
As of September 30, 2024, the Company had no open or pending litigation and no legal reserve was deemed necessary. The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows.
The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.

16
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 8: LEASES
The Company has entered into contractual lease arrangements to rent office space and equipment from third-party lessors and accounts for leases in accordance with ASC Topic 842. See Note 5 to the consolidated financial statements in our 2023 Annual Report. Right of use assets represent the Company’s right to use an underlying asset over the lease term and lease liabilities represent the Company’s obligation to make future lease payments arising from the lease.
Generally, the Company’s operating leases relate to office space used in Mannatech’s operations, including its headquarters in Flower Mound, Texas and office space in international locations in which the Company does business. As of September 30, 2024 and December 31, 2023, all of the Company’s finance leases pertain to certain equipment used in the business.
On March 10, 2023, the Company entered into a five-year agreement to sublease 10,000 rentable square feet of the Company's leased office space in Flower Mound, Texas to a subtenant. There was no modification or impairment by entering into the sublease agreement because the Company was not released from its obligations under the head lease. Sublease income is presented as a component of net sales on the Company's Condensed Consolidated Statements of Operations. The Company has made a policy election in accordance with ASC 842-10-15-39A to exclude from consideration taxes that are assessed on and collected from the sublessee from consideration. For the three and nine months ended September 30, 2024, the Company had earned less than $0.1 million and $0.1 million income from the sublease, respectively. For the three and nine months ended September 30, 2023, the Company had earned less than $0.1 million and $0.1 million income from the sublease, respectively.
As of September 30, 2024, the Company had net operating lease right-of-use assets of $2.5 million and net finance lease right-of-use assets of $1.0 million. At September 30, 2024, our operating lease liabilities were $3.3 million and our finance lease liabilities were $1.0 million.
The weighted-average remaining lease term and discount rate related to the Company’s operating lease liabilities as of September 30, 2024 were 2.82 years and 5.3%, respectively. The weighted-average remaining lease term and discount rate related to the Company’s finance lease liabilities as of September 30, 2024 were 3.54 years and 6.5%, respectively. The Company uses the discount rates implicit in each lease, or an estimate of the Company's incremental borrowing rate if the rate implicit in a lease cannot be readily determined.
As of September 30, 2024 and December 31, 2023 our right-of-use assets and lease liabilities balances, net of accumulated amortization, were as follows (in thousands):
LeasesClassificationSeptember 30, 2024December 31, 2023
Right-of-use assets
Operating leasesOperating lease right-of-use assets$2,532 $3,315 
Finance leasesProperty and equipment, net1,016 1,236 
Total right-of-use assets$3,548 $4,551 
Current portion of lease liabilities
Operating leasesCurrent portion of operating leases$1,508 $1,661 
Finance leasesCurrent portion of finance leases271 269 
Long-term portion of lease liabilities
Operating leasesOperating lease liabilities1,787 2,582 
Finance leasesFinance leases, excluding current portion751 956 
Total lease liabilities$4,317 $5,468 

17
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

As of September 30, 2024, the Company's future sublease income and minimum future lease payments on operating and finance leases were as follows (in thousands):
Future Maturities of LeasesOperating LeasesFinance LeasesSublease Income
Remaining 2024$517 $82 $(33)
20251,334 327 (132)
2026771 327 (132)
2027650 315 (132)
2028268 90 (55)
Total minimum lease payments3,540 1,141 (484)
Imputed interest(245)(119)— 
Present value of minimum lease payments$3,295 $1,022 $(484)
    
18
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 9: FAIR VALUE
The Company utilizes fair value measurements to record fair value adjustments to certain financial assets and to determine fair value disclosures.
Fair Value Measurements and Disclosure (Topic 820) of the Financial Accounting Standards Board (“FASB”) establishes a fair value hierarchy that requires the use of observable market data, when available, and prioritizes the inputs to valuation techniques used to measure fair value in the following categories:
•Level 1 – Quoted unadjusted prices for identical instruments in active markets.
•Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which all observable inputs and significant value drivers are observable in active markets.
•Level 3 – Model-derived valuations in which one or more significant inputs or significant value drivers are unobservable, including assumptions developed by the Company.
The primary objective of the Company’s investment activities is to preserve principal while maximizing yields without significantly increasing risk. The investment instruments held by the Company are money market funds and interest-bearing deposits for which quoted market prices are readily available. The Company considers these highly liquid investments to be cash equivalents. These investments are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company does not have any material financial liabilities that were required to be measured at fair value on a recurring basis at September 30, 2024.
As of September 30, 2024, the Company valued its investment in Korea Mutual Aid Cooperative & Consumer based on the initial investment amount in accordance with ASC 321. The Company determined that the investment was not impaired as of that date. Since these securities are not actively traded, the Company will apply valuation adjustments if and when relevant indicators become available. Consequently, these securities are carried at cost and are classified as Level 3 within the fair value hierarchy.
The tables below present the recorded amount of financial assets and liabilities measured at fair value (in thousands) on a recurring basis as of September 30, 2024 and December 31, 2023. The Company's interest-bearing deposits are measured at amortized cost, which approximates fair value to the carrying value due to the relatively short maturity of the asset, (in thousands). The Company did not have any financial assets measured at fair value on a recurring basis at September 30, 2024 and December 31, 2023. The Company did not have any material financial liabilities that were required to be measured at fair value on a recurring basis at September 30, 2024 and December 31, 2023.
September 30, 2024
Level 1Level 2Level 3Total
Assets    
Money Market Funds – JPMorgan Chase, US$4,332 $— $— $4,332 
Interest bearing deposits – various banks1,082 — — 1,082 
Total assets$5,414 $— $— $5,414 
Amounts included in Assets:    
Cash and cash equivalents$4,332 $— $— $4,332 
Restricted cash675 — — 675 
Long-term restricted cash407 — — 407 
Total$5,414 $— $— $5,414 
Liabilities
Unsecured notes payable$3,600 $— $— $3,600 
   Total Liabilities$3,600 $— $— $3,600 

19
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023
Level 1Level 2Level 3Total
Assets    
Money Market Funds – JPMorgan Chase, US$2,310 $— $— $2,310 
Interest bearing deposits – various banks1,084 — — 1,084 
Total assets$3,394 $— $— $3,394 
Amounts included in Assets:    
Cash and cash equivalents$2,310 $— $— $2,310 
Restricted cash674 — — 674 
Long-term restricted cash410 — — 410 
Total$3,394 $— $— $3,394 
20
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 10: SEGMENT INFORMATION
The Company operates as a direct seller in the nutritional supplement industry. The Company's sole reporting segment is one in which it sells proprietary nutritional supplements, skin care and anti-aging products, and weight-management and fitness products operating in twenty-five markets. The products are primarily sold through a network marketing distribution channel of approximately 136,000 active associates and preferred customer positions who we refer to as current associates and preferred customers. The Company's subsidiary in China, Meitai, is currently operating as a traditional retailer under a cross-border e-commerce model. Meitai cannot legally conduct a direct selling business in China unless it acquires a direct selling license in China. The Company's subsidiary, NEMO, operates an affiliate business model under the brand name, “Trulu,” in the United States. Each of our subsidiaries sells similar products and exhibits similar economic characteristics, such as selling prices, paying commissions and incentives, gross margins and operating characteristics.
Management reviews and analyzes net sales by geographical location and by products and packs on a consolidated basis. The Company currently sells its products in three regions: (i) the Americas (the United States, Canada and Mexico); (ii) Europe/the Middle East/Africa (“EMEA”) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); and (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Hong Kong, Taiwan and China). It also ships products to customers in the following countries: Belgium, France, Greece, Italy, Luxembourg, and Poland.
Consolidated net sales shipped to customers in these regions, along with pack or associate fee and product information for the three and nine months ended September 30, were as follows (in millions, except percentages):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
Region2024202320242023
Americas$10.6 33.4 %$10.7 32.8 %$30.4 34.2 %$31.8 32.0 %
Asia/Pacific18.6 58.7 %19.6 60.1 %51.6 58.0 %60.0 60.4 %
EMEA2.5 7.9 %2.3 7.1 %6.9 7.8 %7.5 7.6 %
Total sales$31.7 100.0 %$32.6 100.0 %$88.9 100.0 %$99.3 100.0 %
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Product sales$30.1 $31.0 $84.3 $93.9 
Pack sales1.3 1.2 3.4 4.7 
Other0.3 0.4 1.2 0.7 
Total sales$31.7 $32.6 $88.9 $99.3 
        Long-lived assets, which include property and equipment and construction in process for the Company and its subsidiaries, as of September 30, 2024 and December 31, 2023, reside in the following regions, as follows (in millions):
RegionSeptember 30, 2024December 31, 2023
Americas$2.6 $3.6 
Asia/Pacific0.5 0.5 
EMEA— — 
Total long-lived assets$3.1 $4.1 
Inventory balances, which consist of raw materials, finished goods, and promotional materials, as offset by the allowance for slow moving or obsolete inventories, reside in the following regions (in millions):
RegionSeptember 30, 2024December 31, 2023
Americas$6.9 $8.3 
Asia/Pacific3.8 4.6 
EMEA1.0 1.6 
Total inventory$11.7 $14.5 

21
MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS


NOTE 11: EARNINGS PER SHARE
    The Company calculates basic Earnings per Share ("EPS") by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted EPS also reflects the potential dilution that could occur if common stock were issued for awards outstanding under the Mannatech, Incorporated 2017 Stock Incentive Plan (described above).
    In determining the potential dilutive effect of outstanding stock options for the three and nine months ended September 30, 2024, the Company used the quarterly and nine-month average common stock close price of $7.32 and $8.01 per share, respectively.
For the three months ended September 30, 2024, the Company's common stock subject to options were excluded from the diluted EPS calculation as their effect would have been antidilutive. The company reported a net loss for the three months ended September 30, 2024.
For the nine months ended September 30, 2024, there were 1.89 million weighted-average common shares outstanding used for the basic EPS calculation. For the nine months ended September 30, 2024, 8,187 shares granted (see Note 5, Stock Based Compensation, for more information). These shares were excluded from the calculation of diluted EPS because the related market condition was not achieved. In addition, 524,122 shares underlying stock options were excluded from the diluted EPS calculation, as their effect would have been antidilutive.
In determining the potential dilutive effect of outstanding stock options for the three and nine months ended September 30, 2023, the Company used the quarterly and nine-month average common stock close price of $11.90 and $14.11 per share, respectively.
For the three months ended September 30, 2023, there were 1.86 million weighted-average common shares outstanding used for the basic EPS calculation. For the three months ended September 30, 2023, approximately 0.2 million shares were excluded from the diluted EPS calculation as their effect would have been antidilutive. The company reported a net loss for the nine months ended September 30, 2023.
Calculation of net EPS— basic and diluted (in thousands, except EPS):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Net earnings attributable to common stockholders$(328)$18 $228 $(483)
Weighted average common shares outstanding (for basic calculation)1,885 1,863 1,885 1,868 
Dilutive effect of outstanding common stock options and RSU’s— — — — 
Weighted average common and common equivalent shares outstanding1,885 1,863 1,885 1,868 
EPS - Basic$(0.17)$0.01 $0.12 $(0.26)
EPS - Diluted$(0.17)$0.01 $0.12 $(0.26)
22

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion is intended to assist in the understanding of our consolidated financial position and results of operations for the three and nine months ended September 30, 2024 as compared to the same period in 2023 and should be read in conjunction with Item 1 “Financial Statements” in Part I of this quarterly report on Form 10-Q and Item 1A “Risk Factors” in Part I of our 2023 Annual Report. Unless stated otherwise, all financial information presented below, throughout this report, and in the condensed consolidated financial statements and related notes includes Mannatech and all of our subsidiaries on a consolidated basis. To supplement our financial results presented in accordance with GAAP, we disclose certain adjusted financial measures which we refer to as Constant dollar (“Constant dollar”) measures, which are non-GAAP financial measures. Refer to the Non-GAAP Financial Measures section herein for a description of how such Constant dollar measures are determined.
COMPANY OVERVIEW
The Company is a global wellness solution provider, which was incorporated and began operations in November 1993. We develop and sell innovative, high quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. We currently sell our products in twenty-five countries which we group into three regions: (i) the Americas (the United States, Canada and Mexico); (ii) Europe/the Middle East/Africa (“EMEA”) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); and (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Thailand, Hong Kong, Taiwan and China). We also ship our products to customers in the following countries: Belgium, France, Greece, Italy, Luxembourg, and Poland. During the second quarter of 2024 the Company liquidated its entity in Sweden, Mannatech Sverige AB.
We conduct our business as a single operating segment and primarily sell our products through a network of approximately 136,000 active associates and preferred customer positions held by individuals that purchased our products and/or packs or paid associate fees during the last twelve months, who we refer to as current associates and preferred customers. New pack sales and the receipt of new associate fees in connection with new positions in our network are leading indicators for the long-term success of our business. New associate or preferred customer positions are created in our network when our associate fees are paid, or packs and products are purchased for the first time under a new account. We review and analyze net sales by geographical location and by packs and products on a consolidated basis. Each of our subsidiaries sells similar products and exhibits similar economic characteristics, such as selling prices and gross margins.
Because we sell our products principally through network marketing distribution channels, the opportunities and challenges that affect us most are: recruitment of new and retention of current associates and preferred customers that occupy sales or purchasing positions in our network; entry into new markets and growth of existing markets; niche market development; new product introduction; and investment in our infrastructure. Our subsidiary in China, Meitai, is currently operating as a traditional retailer under a cross-border e-commerce model. Meitai cannot legally conduct a direct selling business in China unless it acquires a direct selling license in China.
The Company maintains a corporate website at www.mannatech.com.
Overview of Operating Results
Consolidated net sales for the three months ended September 30, 2024 was $31.7 million, as compared to $32.6 million for the three months ended September 30, 2023, a decrease of $0.9 million, or 2.5%. Consolidated net sales for the nine months ended September 30, 2024 was $88.9 million, as compared to $99.3 million for the nine months ended September 30, 2023, a decrease of $10.4 million, or 10.5%. The decline in revenues was principally due to slowing demand in Asia due to weakened economic conditions, relative to the prior year.
The decrease in revenue during the nine months ended September 30, 2024 was accompanied by a 2.2% decrease in gross profit margins, primarily due to increases in product costs and $0.6 million of inventory markdowns. To mitigate the impacts to profitability, management continued to prioritize the reduction of selling and administrative expenses, which yielded a $4.3 million reduction in payroll costs and $1.5 million reduction in consulting and professional services costs, compared with the nine months ended September 30, 2023.
Net realized and unrealized foreign currency loss for the quarter ended September 30, 2024 was $1.5 million, primarily related to the effects of translation of the Company's balance sheet as the U.S. Dollar strengthened relative to other currencies. The quarter ended September 30, 2023 resulted in a foreign exchange gain of $0.3 million.
Net realized and unrealized foreign currency gains for the nine months ended September 30, 2024 and September 30, 2023 were $0.5 million and $0.8 million, respectively. These were primarily related to the effects of translation gains and losses on the Company's balance sheet as the U.S. Dollar strengthened relative to other currencies. Foreign currency gains also included a one-time gain of $0.2 million during the quarter ended September 30, 2024 attributable to the liquidation of the Company’s entity in Sweden.
Net loss was $0.3 million for the three months ended September 30, 2024, or $0.17 per diluted share, as compared to net income of $18,000, or $0.01 per diluted share for the three months ended September 30, 2023.
Net income was $0.2 million for the nine months ended September 30, 2024, or $0.12 per diluted share, as compared to a net loss of $0.5 million , or $0.26 per diluted share for the nine months ended September 30, 2023.
23

RESULTS OF OPERATIONS
Three Months Ended September 30, 2024 Compared to Three Months Ended September 30, 2023
The table below summarizes our consolidated operating results in dollars and as a percentage of net sales for the three months ended September 30, 2024 and 2023 (in thousands, except percentages):
 20242023Change from
2023 to 2024
 Total
dollars		% of
net sales		Total
dollars		% of
net sales		DollarPercentage
Net sales$31,725 100.0 %$32,553 100.0 %$(828)(2.5)%
Cost of sales8,105 25.5 %6,625 20.4 %1,480 22.3 %
Gross profit23,620 74.5 %25,928 79.6 %(2,308)(8.9)%
Operating expenses:
Commissions and incentives12,893 40.6 %13,178 40.5 %(285)(2.2)%
Selling and administrative expenses9,840 31.0 %12,578 38.6 %(2,738)(21.8)%
Total operating expenses22,733 71.7 %25,756 79.1 %(3,023)(11.7)%
Income from operations887 2.8 %172 0.5 %715 415.7 %
Interest expense, net(109)(0.3)%(17)(0.1)%(92)541.2 %
Other (expense) income, net(1,495)(4.7)%320 1.0 %(1,815)(567.2)%
(Loss) income before income taxes(717)(2.3)%475 1.5 %(1,192)(250.9)%
Income tax benefit (expense)389 1.2 %(457)(1.4)%846 (185.1)%
Net (loss) income$(328)(1.0)%$18 0.1 %$(346)(1,922.2)%

Nine Months Ended September 30, 2024 Compared to Nine Months Ended September 30, 2023

The table below summarizes our consolidated operating results in dollars and as a percentage of net sales for the nine months ended September 30, 2024 and 2023 (in thousands, except percentages):

20242023Change from
2022 to 2023
Total
dollars		% of
net sales		Total
dollars		% of
net sales		DollarPercentage
Net sales$88,858 100.0 %$99,261 100.0 %$(10,403)(10.5)%
Cost of sales20,763 23.4 %21,042 21.2 %(279)(1.3)%
Gross profit68,095 76.6 %78,219 78.8 %(10,124)(12.9)%
Operating expenses:  
Commissions and incentives36,237 40.8 %40,200 40.5 %(3,963)(9.9)%
Selling and administrative expenses31,293 35.2 %38,088 38.4 %(6,795)(17.8)%
Total operating expenses67,530 76.0 %78,288 78.9 %(10,758)(13.7)%
Income (loss) from operations565 0.6 %(69)(0.1)%634 (918.8)%
Interest expense, net(196)(0.2)%(3)— %(193)6,433.3 %
Other income, net495 0.6 %803 0.8 %(308)(38.4)%
Income before income taxes864 1.0 %731 0.7 %133 18.2 %
Income tax provision(636)(0.7)%(1,214)(1.2)%578 (47.6)%
Net income (loss)$228 0.3 %$(483)(0.5)%$711 (147.2)%
24

Non-GAAP Financial Measures
To supplement our financial results presented in accordance with GAAP, we disclose operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Income from Operations. We refer to these adjusted financial measures as Constant dollar items, which are non-GAAP financial measures. We believe these measures provide investors an additional perspective on trends and our operating results. To exclude the impact of changes due to the translation of foreign currencies into U.S. dollars in the current year, we calculate current year results at a constant exchange rate utilizing the prior year’s rate. Currency impact is determined as the difference between the actual GAAP results and the recalculated results for the current year at the Constant dollar rates.
For the three and nine months ended September 30, 2024, our net sales decreased $0.4 million and $8.5 million, or 1.2% and 8.6% on a Constant dollar basis, respectively (see reconciliation of Non-GAAP Financial Measures in the tables below); and unfavorable foreign exchange caused a $0.5 million and $1.9 million decrease in GAAP net sales as compared to the same periods in 2023, respectively.
A reconciliation non-GAAP financial measures to GAAP results for the three and nine months ended September 30, 2024 and 2023 is presented as follows (in millions, except percentages):
Three-month period ended September 30, 2024September 30, 2023Constant $ Change

GAAP
Measure:
Total $		Translation AdjustmentNon-GAAP
Measure:
Constant $		GAAP
Measure:
Total $		DollarPercent
Net sales$31.7 $0.5 $32.2 $32.6 $(0.4)(1.2)%
Gross profit23.6 0.4 24.0 25.9 (1.9)(7.3)%
Income from operations0.9 0.1 1.0 0.2 0.8 400.0 %
Nine-month period endedSeptember 30, 2024September 30, 2023Constant $ Change
GAAP
Measure:
Total $		Translation AdjustmentNon-GAAP
Measure:
Constant $		GAAP
Measure:
Total $		DollarPercent
Net sales$88.9 $1.9 $90.8 $99.3 $(8.5)(8.6)%
Gross profit68.1 1.569.6 78.2 (8.6)(11.0)%
Income (loss) from operations0.6 $0.5 1.1 (0.1)1.2 (1,200.0)%

Net Sales by Region
Operations outside of the Americas accounted for approximately 66.6% of our consolidated net sales in the three months ended September 30, 2024, as compared to 67.2% in the same period last year. Our operations outside of the Americas accounted for approximately 65.8% of our consolidated net sales in the nine months ended September 30, 2024, as compared to 68.0% in the same period last year.
Consolidated net sales by region for the three months ended September 30, 2024 and 2023 were as follows (in millions, except percentages):
RegionThree Months Ended
September 30, 2024		Three Months Ended
September 30, 2023
Americas$10.6 33.4 %$10.7 32.8 %
Asia/Pacific18.6 58.7 %19.6 60.1 %
EMEA2.5 7.9 %2.3 7.1 %
Total$31.7 100.0 %$32.6 100.0 %
25

Consolidated net sales by region for the nine months ended September 30, 2024 and 2023 were as follows (in millions, except percentages):
RegionNine Months Ended
September 30, 2024		Nine Months Ended
September 30, 2023
Americas$30.4 34.2 %$31.8 32.0 %
Asia/Pacific51.6 58.0 %60.0 60.4 %
EMEA6.9 7.8 %7.5 7.6 %
Total$88.9 100.0 %$99.3 100.0 %

For the three months ended September 30, 2024, net sales in the Americas decreased by $0.1 million, or 0.9%, to $10.6 million, as compared to $10.7 million for the same period in 2023. The number of active independent associates and preferred customers decreased by 3.7%, which was partially offset by a 2.9% increase in revenue per active independent associate and preferred customer. Foreign currency had the effect of decreasing revenue by $0.2 million for the three months ended September 30, 2024 when compared to the same period in 2023. The currency impact is primarily due to the weakening of the Mexican Peso.
For the nine months ended September 30, 2024, net sales in the Americas decreased by $1.4 million, or 4.4%, to $30.4 million, as compared to $31.8 million for the same period in 2023. Revenue per active independent associate and preferred customer decreased 0.7%, which was partially offset by a 0.5% increase in number of active independent associates and preferred customers. Foreign currency had no effect on revenue in the Americas for the nine months ended September 30, 2024, as compared to the same period in 2023.
For the three months ended September 30, 2024, Asia/Pacific net sales decreased by $1.0 million, or 5.1%, to $18.6 million, as compared to $19.6 million for the same period in 2023. The number of active independent associates and preferred customers decreased by 9.2%, which was partially offset by a 4.5% increase in revenue per active independent associate and preferred customer. Foreign currency exchange had the effect of decreasing revenue by $0.4 million for the three months ended September 30, 2024, as compared to the same period in 2023. The currency impact is primarily due to the weakening of the Korean Won.
For the nine months ended September 30, 2024, Asia/Pacific net sales decreased by $8.4 million, or 14%, to $51.6 million, as compared to $60.0 million for the same period in 2023. A challenging economic environment in Korea led to a 5.3% decrease in revenue per active independent associate and preferred customer, which was partially offset by a 1.5% increase in the number of active independent associates and preferred customers. Foreign currency exchange had the effect of decreasing revenue by $2.0 million for the nine months ended September 30, 2024, as compared to the same period in 2023. The currency impact is primarily due to the weakening of the Korean Won and Japanese Yen.
For the three months ended September 30, 2024, EMEA net sales increased by $0.2 million, or 8.7%, to $2.5 million, as compared to $2.3 million for the same period in 2023. The increase was primarily due to a 16.2% increase in revenue per active independent associate and preferred customer, which was partially offset by a 6.4% decrease in the number of active independent associates and preferred customers. Foreign currency exchange had the effect of increasing revenue by $0.1 million for the three months ended September 30, 2024 as compared to the same period in 2023. The currency impact is primarily due to the weakening of the South African Rand.
For the nine months ended September 30, 2024, EMEA net sales decreased by $0.6 million, or 8%, to $6.9 million, as compared to $7.5 million for the same period in 2023. The decrease was primarily due to a 10.6% decrease in the number of active independent associates and preferred customers and a 1.7% decrease in revenue per active independent associate and preferred customer. Foreign currency exchange had a minimal effect on revenue for the three months ended September 30, 2024 as compared to the same period in 2023.

Sales Mix
Our sales mix for the three and nine months ended September 30, was as follows (in millions, except percentages):
Three-month period endedSeptember 30, 2024September 30, 2023Constant $ Change
GAAP
Measure:
Total $		Translation AdjustmentNon-GAAP
Measure:
Constant $		GAAP
Measure:
Total $		DollarPercent
Product$30.1 $0.4 $30.5 $31.0 $(0.5)(1.6)%
Pack sales and associate fees1.3 — 1.3 1.2 0.1 8.3 %
Other0.3 0.1 0.4 0.4 — — %
Total$31.7 $0.5 $32.2 $32.6 $(0.4)(1.2)%
26


Nine-month period endedSeptember 30, 2024September 30, 2023Constant $ Change
GAAP
Measure:
Total $		Translation AdjustmentNon-GAAP
Measure:
Constant $		GAAP
Measure:
Total $		DollarPercent
Product$84.3 $1.8 $86.1 $93.9 $(7.8)(8.3)%
Pack sales and associate fees3.4 0.13.5 4.7 (1.2)(25.5)%
Other1.2 — 1.2 0.7 0.5 71.4 %
Total$88.9 $1.9 $90.8 $99.3 $(8.5)(8.6)%

Product Sales
Our product sales consist primarily of sales made to our independent associates and preferred customers at published wholesale prices. Product sales for the three months ended September 30, 2024 decreased by $0.9 million, or 2.9%, as compared to the same period in 2023. On a Constant dollar basis, product sales for the three months ended September 30, 2024 decreased $0.5 million, or 1.6%, as compared to the same period in 2023. The decrease in product sales for the three months ended September 30, 2024 reflects a 6.4% decrease in the number of orders processed and a decrease in the average order value to $178, as compared to $177 for the same period in 2023.
The Company experienced supply chain issues with some products during 2024, which led to stock outs of certain products and affected the timing of certain key product promotions during the year. Product sales for the nine months ended September 30, 2024 decreased by $9.6 million, or 10.2%, as compared to the same period in 2023. On a Constant dollar basis, product sales for the nine months ended September 30, 2024 declined $7.8 million, or 8.3%, as compared to the same period in 2023. The decrease in product sales for the nine months ended September 30, 2024 reflects a 7.2% decrease in the number of orders processed and a decrease in the average order value to $171, as compared to $178 for the same period in 2023.

Pack sales, Associate Fees and Recruiting
Recruitment of new independent associates and preferred customers decreased by 28.1% to 16,741 in the third quarter of 2024, as compared with 23,296 in the third quarter of 2023. We attribute the lower number of orders processed in the three months ended September 30, 2024 to a combination of the lower number of new independent associates and preferred customers recruited during the period.
Pack sales and associate fees are closely related to recruiting and retention of business-building associates. The approximate number of new and continuing active independent associates and preferred customers who purchased our packs or products or paid associate fees during the twelve months ended September 30, 2024 and 2023 were as follows:
 20242023
New68,000 50.0 %78,000 53.4 %
Continuing68,000 50.0 %68,000 46.6 %
Total136,000 100.0 %146,000 100.0 %

The Company collects associate fees in lieu of selling packs in certain markets. Associate fees are paid annually by new and continuing associates to the Company, which entitle them to earn commissions, benefits and incentives for that year. The Company collected associate fees in lieu of pack sales within the United States, Canada, South Africa, Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, the Netherlands, Norway, Spain, Sweden the United Kingdom. Japan, Australia, New Zealand, Singapore, Hong Kong, and Taiwan.
In the Republic of Korea and Mexico, packs may still be purchased by our associates who wish to build a Mannatech business. These packs contain products that are discounted from both the published retail and associate prices. There are several pack options available to our associates. In certain of these markets, pack sales are completed during the final stages of the registration process and can provide new associates with valuable training and promotional materials, as well as products for resale to retail customers, demonstration purposes, and personal consumption. Business-building associates in these markets can also purchase an upgrade pack, which provides the associate with additional promotional materials. The decline in pack sales occurred principally in Korea.
We do not collect associate fees or sell packs in our non-direct selling business in mainland China.


27

Other Sales
Other sales consisted of: (i) sales of promotional materials; (ii) monthly fees collected for the Success Tracker™ and Mannatech+ customized electronic business-building and educational materials, databases and applications; (iii) training and event registration fees; and (iv) a reserve for estimated sales refunds and returns. Promotional materials, training, database applications and business management tools support our independent associates, which in turn helps stimulate product sales.         
For the three months ended September 30, 2024 and 2023, other sales were $0.3 million and $0.4 million, respectively.
For the nine months ended September 30, 2024 and 2023, other sales were $1.2 million and $0.7 million, respectively.

Gross Profit
For the three months ended September 30, 2024, gross profit decreased by $2.3 million, or 8.9%, to $23.6 million, as compared to $25.9 million for the same period in 2023. For the three months ended September 30, 2024, gross profit as a percentage of net sales decreased to 74.5%, as compared to 79.6% for the same period in 2023. The decrease in gross profit in dollar terms is principally due to increased product costs, including inventory markdowns, and increased freight costs. The timing of certain sales promotions also reduced gross profit as a percentage of net sales during the quarter, compared with the same period in 2023.
For the nine months ended September 30, 2024, gross profit decreased by $10.1 million, or 12.9%, to $68.1 million, as compared to $78.2 million for the same period in 2023. The decrease in gross profit in dollar terms is principally due to increased costs related to supply chain challenges, including increased product costs and increased freight costs. For the nine months ended September 30, 2024, gross profit as a percentage of net sales decreased to 76.6%, as compared to 78.8% for the same period in 2023.

Commissions and Incentives
Commission expense for the three months ended September 30, 2024 decreased by 2.0%, or $0.2 million, to $12.2 million, as compared to $12.4 million for the same period in 2023. Commissions are earned on sales. Commission expense in dollar terms decreased during the three months ended September 30, 2024 primarily due to a decline in our sales. For the three months ended September 30, 2024, commissions as a percentage of net sales remained constant at 38.3%.
Commission expense for the nine months ended September 30, 2024 decreased by 9.2%, or $3.5 million, to $34.5 million, as compared to $38.0 million for the same period in 2023. Commissions are earned on sales. Commission expense in dollar terms decreased during the nine months ended September 30, 2024 primarily due to a decline in our sales. For the nine months ended September 30, 2024, commissions as a percentage of net sales increased to 38.8% from 38.3% for the same period in 2023.
Incentive costs for the three months ended September 30, 2024 and 2023 remained constant at $0.7 million. For the three months ended September 30, 2024, incentives as a percentage of net sales remained constant at 2.3%.
Incentive costs for the nine months ended September 30, 2024 decreased to $1.8 million, as compared to $2.2 million for the same period in 2023 . For the nine months ended September 30, 2024, incentives as a percentage of net sales decreased to 2.0% from 2.2% for the same period in 2023. The decrease was related to travel incentives in the Americas and Asia/Pacific.

28

Selling and Administrative Expenses
Selling and administrative expenses include a combination of both fixed and variable expenses. These expenses consist of compensation and benefits for employees; temporary and contract labor; accounting, legal and consulting fees; compensation to our board of directors; warehouse and fulfillment costs; depreciation and amortization; marketing-related expenses; travel and entertainment expenses; credit card processing fees; costs for software maintenance agreements; insurance; charitable contributions; office lease expense; utilities; bad debt; and other miscellaneous operating expenses.
For the three months ended September 30, 2024, selling and administrative expenses decreased by $2.8 million, or 21.8%, to $9.8 million, as compared to $12.6 million for the same period in 2023. The decrease in selling and administrative expenses was the result of a $0.9 million reduction in payroll costs, a $0.6 million decrease in marketing costs, a $0.6 million decrease to bad debt, a $0.3 million decrease in professional and consulting fees, a $0.2 million decrease in office expenses, $0.1 million decrease in depreciation expense and a $0.1 million decrease in travel and entertainment costs. Selling and administrative expenses, as a percentage of net sales, for the three months ended September 30, 2024 decreased to 31.0% from 38.6% for the same period in 2023.
For the nine months ended September 30, 2024, selling and administrative expenses decreased by $6.8 million, or 17.8%, to $31.3 million, as compared to $38.1 million for the same period in 2023. The decrease in selling and administrative expenses was the result of judicious cost reductions, including a $2.3 million decrease in payroll costs, a $1.7 million decrease in professional and consulting fees, a $0.9 million decrease in marketing costs, a $0.6 million decrease to bad debt, a $0.5 million decrease in costs of office space, a $0.4 million decrease in travel and entertainment costs, a $0.2 million decrease in contract labor costs and a $0.2 million decrease in credit card fees. Selling and administrative expenses, as a percentage of net sales, for the nine months ended September 30, 2024 decreased to 35.2% from 38.4% for the same period in 2023.


Other Income (Expense), Net
Foreign exchange losses were $1.5 million for the three months ended September 30, 2024. Foreign exchange gains were $0.3 million for the three months ended September 30, 2023.
Foreign exchange gains were $0.5 million and $0.8 million for the nine months ended September 30, 2024 and 2023, respectively.

Income Tax (Provision) Benefit
    Income tax benefit was $0.4 million for the three months ended September 30, 2024 as compared to income tax expense of $0.5 million in the same period last year.
Income tax (provision) or benefit includes current and deferred income taxes for both our domestic and foreign operations. Our statutory income tax rates for key jurisdictions are as follows, for the nine months ended September 30:
Country20242023
China(1)
25.0 %25.0 %
Hong Kong16.5 %16.5 %
Japan34.6 %34.6 %
Republic of Korea20.9 %20.9 %
United States(2)
22.2 %22.2 %
(1)For 2024, the Company qualified for a reduced tax rate of 5% in China as a Small Low Profit Enterprise.
(2) Includes blended state effective rate of 1.2% for 2024 and 2023 in addition to U.S. federal statutory rate of 21%.

Income from our international operations is subject to taxation in the countries in which we operate. Although we may receive foreign income tax credits that would reduce the total amount of income taxes owed in the United States, we may not be able to fully utilize our foreign income tax credits in the United States.
We use the recognition and measurement provisions of the FASB ASC Topic 740, Income Taxes (“Topic 740”), to account for income taxes. The provisions of Topic 740 require a company to record a valuation allowance when the “more likely than not” criterion for realizing net deferred tax assets cannot be met. Furthermore, the weight given to the potential effect of such evidence should be commensurate with the extent to which it can be objectively verified. As a result, we reviewed the operating results, as well as all of the positive and negative evidence related to realization of such deferred tax assets to evaluate the need for a valuation allowance in each tax jurisdiction.
The provision for income taxes is directly related to our profitability and changes in the taxable income across countries of operation. For the three and nine months ended September 30, 2024, the Company’s effective tax rate was 83.9%
29

and 71.1%, respectively. For the three and nine months ended September 30, 2023, the Company’s effective tax rate was 43.0% and 166.1%, respectively.
The effective tax rates for the three and nine months ended September 30, 2024 and 2023 was different from the federal statutory rate due primarily to the mix of earnings across jurisdictions and the associated valuation allowances recorded on losses in certain jurisdictions.

30

LIQUIDITY AND CAPITAL RESOURCES
Cash and Cash Equivalents
As of September 30, 2024, our cash and cash equivalents increased by 57.2%, or $4.5 million, to $12.2 million from $7.7 million as of December 31, 2023. The Company is required to restrict cash for: (i) direct selling insurance premiums and credit card sales in the Republic of Korea; (ii) reserves related to credit card sales in the United States and Canada; and (iii) collateral for a building lease in Australia. The current portion of restricted cash balances was $0.9 million at each of September 30, 2024 and December 31, 2023. The long-term portion of restricted cash balances was $0.6 million and $0.7 million at September 30, 2024 and December 31, 2023, respectively.
Our principal use of cash is to pay for operating expenses, including commissions and incentives, capital assets, inventory purchases, and periodic cash dividends. We did not pay a dividend in the current quarter. Business objectives, operations, and expansion of operations are funded through net cash flows from operations rather than incurring long-term debt.

Working Capital
Working capital represents total current assets less total current liabilities. At September 30, 2024 and December 31, 2023, our working capital was $5.7 million and $1.9 million, respectively.

Net Cash Flows
Our net consolidated cash flows consisted of the following, for the nine months ended September 30 (in millions):
Provided by (Used in):20242023
Operating activities$2.5 $(1.0)
Investing activities$(0.4)$(0.5)
Financing activities$2.9 $(1.6)

Operating Activities
Operating activities provided $2.5 million cash for the nine months ended September 30, 2024 as compared to a use of $1.0 million cash in the same period in 2023. The improvement is due to reduced operating costs and management of inventory carrying balances over the nine months ended September 30, 2024.
Investing Activities
For the nine months ended September 30, 2024 and 2023, we invested cash of $0.4 million and $0.5 million, respectively, principally for back-office software projects, reported as property and equipment.

Financing Activities
For the nine months ended September 30, 2024 our financing activities provided cash of $2.9 million. We received $3.6 million from the issuance of notes payable (see Note 4) and we used $0.7 million in the repayment of finance lease obligations.
For the nine months ended September 30, 2023 our financing activities used $1.6 million. For the nine months ended September 30, 2023, we used $0.7 million in payments of dividends to shareholders, $0.7 million in the repayment of finance lease obligations and $0.2 million in the repurchase of common stock.

31

General Liquidity and Cash Flows

Short Term Liquidity
As of September 30, 2024, our cash and cash equivalents was $12.2 million. We believe our existing liquidity and cash flows from operations are adequate to fund our normal expected future business operations for the next twelve months.
On April 23, 2024, the Company entered into unsecured Loan and Promissory Note agreements with three related parties, who are members of the Company’s Board of Directors, and who are current stockholders of the Company, in an aggregate principal amount of $3.6 million. The purpose of the borrowing was to provide funds to the Company for general working capital needs, including payment to vendors, expansion of the Company’s non-US operations, technology investment primarily for improving the customer ordering process and software updates to improve visibility of sales associate activity.
We have contractual purchase commitments with certain raw materials suppliers to purchase minimum quantities. At September 30, 2024, we have one supply agreement which was amended on April 18, 2024, that requires the Company to purchase an aggregate of $1.8 million through 2025, with no purchase commitments thereafter. We also maintain other supply agreements and manufacturing agreements to protect our products, regulate product costs, and help ensure quality control standards. These agreements do not require us to purchase any minimum quantities.
We have operating lease liabilities for the property and equipment we use in our business operations. These operating lease liabilities represent our minimum future payment obligations on operating leases, including imputed interest. At September 30, 2024, our operating lease liabilities were $3.3 million, of which $1.5 million is presented as the current portion and $1.8 million is presented as Operating lease liabilities excluding current portion on our Condensed Consolidated Balance Sheets. We also have finance lease liabilities of $1.0 million and lease restoration liabilities of $0.4 million.
As our primary source of liquidity has historically been our cash flows from operations, our liquidity is dependent on our ability to maintain and/or continue to improve revenue as compared to our operational expenses. In this regard, our management has established a 2024 business reorganization plan focusing on revenue growth, margin improvement and cost control and reduction, including a plan to improve margin through a price increase, continued focus on supply chain costs, and certain compensation plan adjustments, as well as to reorganize certain functional operations and reduce our fixed selling and administrative overhead.
However, if our reorganization plans are not successful, or if we experience further or unexpected disruption in our supply chain, and/or potential decreases in consumer demands, our sales and our overall liquidity in the next twelve months could be negatively impacted. If our existing capital resources or cash flows become insufficient to meet current business plans, projections, and existing capital requirements, we may be required to raise additional funds, which may not be available on favorable terms, if at all.

Long Term Liquidity
We believe our cash flows from operations should be adequate to fund our normal expected future business operations and possible international expansion costs for the long term. As our primary source of liquidity is from our cash flows from operations, this will be dependent on our ability to maintain or improve revenue as compared to operational expenses.
However, if our existing capital resources or cash flows become insufficient to meet anticipated business plans and existing capital requirements, we may be required to raise additional funds, which may not be available on favorable terms, if at all.
Our future access to the capital markets may be adversely impacted if we fail to maintain compliance with the Nasdaq Marketplace Rules for the continued listing of our stock. We continuously monitor our compliance with the Nasdaq continued listing rules.

32



OFF-BALANCE SHEET ARRANGEMENTS
We do not have any special-purpose entity arrangements, nor do we have any off-balance sheet arrangements.


CRITICAL ACCOUNTING ESTIMATES
Our condensed consolidated financial statements are prepared in accordance with GAAP. The application of GAAP requires us to make estimates and assumptions that affect the reported values of assets and liabilities at the date of our financial statements, the reported amounts of revenues and expenses during the reporting period, and the related disclosures of contingent assets and liabilities. We use estimates throughout our financial statements, which are influenced by management’s judgment and uncertainties. Our estimates are based on historical trends, industry standards, and various other assumptions that we believe are applicable and reasonable under the circumstances at the time the condensed consolidated financial statements are prepared. Our Audit Committee reviews our significant accounting policies and critical estimates. We continually evaluate and review our policies related to the portrayal of our consolidated financial position and consolidated results of operations that require the application of significant judgment by our management. We also analyze the need for certain estimates, including the need for such items as allowance for credit losses, inventory reserves, long-lived fixed assets and capitalization of internal-use software development costs, reserve for uncertain income tax positions and tax valuation allowances, revenue recognition, sales returns, and deferred revenues, accounting for stock-based compensation, and contingencies and litigation. Historically, actual results have not materially deviated from our estimates. However, we caution readers that actual results could differ from our estimates and assumptions applied in the preparation of our condensed consolidated financial statements. If circumstances change relating to the various assumptions or conditions used in our estimates, we could experience an adverse effect on our financial position, results of operations, and cash flows. We have identified the following applicable significant accounting policies and critical estimates as of September 30, 2024.

Inventory Reserves
Inventory consists of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. We record the amounts charged by the vendors as the costs of inventory. Typically, the net realizable value of our inventory is higher than the aggregate cost. Determination of net realizable value can be complex and, therefore, requires a high degree of judgment. In order for management to make the appropriate determination of net realizable value, the following items are considered: inventory turnover statistics, current selling prices, seasonality factors, consumer demand, regulatory changes, competitive pricing, and performance of similar products. If we determine the carrying value of inventory is in excess of estimated net realizable value, we write down the value of inventory to the estimated net realizable value.
We also review inventory for obsolescence in a similar manner and any inventory identified as obsolete is reserved or written off. Our determination of obsolescence is based on assumptions about the demand for our products, product expiration dates, estimated future sales, and general future plans. We monitor actual sales compared to original projections, and if actual sales are less favorable than those originally projected by us, we record an additional inventory reserve or write-down. Historically, our estimates have been close to our actual reported amounts. However, if our estimates regarding inventory obsolescence are inaccurate or consumer demand for our products changes in an unforeseen manner, we may be exposed to additional material losses or gains in excess of our established estimated inventory reserves.

Tax Valuation Allowances
    As of September 30, 2024, there was nothing recorded in other long-term liabilities on our condensed consolidated balance sheet related to uncertain income tax positions. As required by Topic 740, we use judgments and make estimates and assumptions related to evaluating the probability of uncertain income tax positions. We base our estimates and assumptions on the potential liability related to an assessment of whether the income tax position will “more likely than not” be sustained in an income tax audit. We are also subject to periodic audits from multiple domestic and foreign tax authorities related to income tax and other forms of taxation. These audits examine our tax positions, timing of income and deductions, and allocation procedures across multiple jurisdictions. Depending on the nature of the tax issue, we could be subject to audit over several years. There are ongoing income tax audits in various international jurisdictions that we believe are not material to our financial statements.
    
Revenue Recognition and Deferred Commissions
Our revenue is derived from sales of individual products and associate fees or, in certain geographic markets, starter packs. Substantially all of our product and pack sales are to associates and preferred customers at published wholesale prices. We record revenue net of any sales taxes and record a reserve for expected sales returns based on historical experience. During
33

the quarter ended September 30, 2024 the Company changed its shipping terms with customers such that ownership transfers upon delivery to the freight carrier, satisfying the Company's performance obligation. Previously, the Company's shipping terms were FOB destination, so the Company recognized revenue upon delivery of the product to the customer. We recorded the value of orders shipped but not yet delivered to customers as Deferred revenue on our Consolidated Balance Sheet. Corporate-sponsored event revenue is recognized when the event is held.
Orders placed by associates or preferred customers constitute our contracts. Product sales placed in the form of an automatic order contain two performance obligations: (1) the sales of the product and (2) the loyalty program. For these contracts, we account for each of these obligations separately as they are each distinct. The transaction price is allocated between the product sale and the loyalty program on a relative standalone selling price basis. Sales placed through a one-time order contain only the first performance obligation noted above – the sale of the product.
We provide associates with access to a complimentary three-month package for the Success Tracker™ and Mannatech+ online business tools with the first payment of an associate fee. The first payment of an associate fee contains three performance obligations: (1) providing new associates with the eligibility to earn commissions, bonuses and incentives for twelve months, (2) three months of complimentary access to utilize the Success Tracker™ online tool, and (3) three months of complimentary access to utilize the Mannatech+ online business tool. The transaction price is allocated between the three performance obligations on a relative standalone selling price basis. Associates do not have complimentary access to online business tools after the first contractual period.
With regard to both of the aforementioned contracts, we determine the standalone selling prices by using observable inputs, which include our standard published price lists.

Product Return Policy
We stand behind our packs and products and believe we offer a reasonable and industry-standard product return policy to all of our customers. We do not resell returned products. Refunds are not processed until proper approval is obtained. All refunds must be processed and returned in the same form of payment that was originally used in the sale. Each country in which we operate has specific product return guidelines. However, we allow our associates and preferred customers to exchange products as long as the products are unopened and in good condition. Our return policies for our retail customers and our associates and preferred customers are as follows:
•Retail Customer Product Return Policy. This policy allows a retail customer to return any of our products to the original associate who sold the product and receive a full cash refund from the associate for the first 180 days following the product’s purchase if located in the United States and Canada, and for the first 90 days following the product’s purchase in other countries where we sell our products. The associate may then return or exchange the product based on the associate product return policy.
•Associate and Preferred Customer Product Return Policy. This policy allows the associate or preferred customer to return an order within one year of the purchase date upon terminating his/her account. If an associate or preferred customer returns a product unopened and in good condition, he/she may receive a full refund minus a 10% restocking fee. We may also allow the associate or preferred customer to receive a full satisfaction guarantee refund if they have tried the product and are not satisfied for any reason, excluding promotional materials. This satisfaction guarantee refund applies in the United States and Canada, only for the first 180 days following the product’s purchase and applies in other countries where we sell our products for the first 90 days following the product’s purchase; however, any commissions earned by an associate will be deducted from the refund. If we discover abuse of the refund policy, we may terminate the associate’s or preferred customer’s account.
Historically, sales returns estimates have not materially deviated from actual sales returns, as the majority of our customers who return merchandise do so within the first 90 days after the original sale. Based upon our return policies and historical experience, we estimate a sales return reserve for expected sales refunds over a rolling six-month period. If actual results differ from our estimated sales returns reserves due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years and have averaged 0.5% or less of our gross sales.


34

Item 3.    Quantitative and Qualitative Disclosures About Market Risk
We do not engage in trading market risk sensitive instruments and do not purchase investments as hedges or for purposes “other than trading” that are likely to expose us to certain types of market risk, including interest rate, commodity price, or equity price risk. Although we have investments, we believe there has been no material change in our exposure to interest rate risk. We have not issued any debt instruments, entered into any forward or futures contracts, purchased any options, or entered into any swap agreements.
We are exposed, however, to other market risks, including changes in currency exchange rates as measured against the United States dollar. Because the change in value of the United States dollar measured against foreign currency may affect our consolidated financial results, changes in foreign currency exchange rates could positively or negatively affect our results as expressed in United States dollars. For example, when the United States dollar strengthens against foreign currencies in which our products are sold or weakens against foreign currencies in which we may incur costs, our consolidated net sales or related costs and expenses could be adversely affected. We translate our revenues and expenses in foreign markets using an average rate.
We maintain policies, procedures, and internal processes in an effort to help monitor any significant market risks and we do not use any financial instruments to manage our exposure to such risks. We assess the anticipated foreign currency working capital requirements of our foreign operations and maintain a portion of our cash and cash equivalents denominated in foreign currencies sufficient to satisfy most of these anticipated requirements.
We caution that we cannot predict with any certainty our future exposure to such currency exchange rate fluctuations or the impact, if any, such fluctuations may have on our future business, product pricing, operating expenses, and on our consolidated financial position, results of operations, or cash flows. However, to combat such market risk, we closely monitor our exposure to currency fluctuations.



35

Item 4.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer (principal executive officer) and our Chief Financial Officer (principal financial officer), have concluded, based on their evaluation as of the end of the period covered by this report, that our disclosure controls and procedures (as defined in Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act) are effective to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and include controls and procedures designed to ensure that information required to be disclosed by us in such reports is accumulated and communicated to our management, including our principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting
    During the quarter ended September 30, 2024, there were no changes in our internal control over our financial reporting that we believe materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
36

PART II - OTHER INFORMATION

Item 1.    Legal Proceedings
See Note 7, Litigation, of our Notes to Unaudited Condensed Consolidated Financial Statements, which is incorporated herein by reference.

Item 1A.    Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2023 Annual Report, which could materially affect our business or our consolidated financial position, results of operations, and cash flows. The risks described in our 2023 Annual Report are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be insignificant also may become materially adverse or may affect our business in the future or our consolidated financial position, results of operations, or cash flows.





37

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

None.


Item 3.    Defaults Upon Senior Securities

None.

Item 4.    Mine Safety Disclosures

Not Applicable.

Item 5.    Other Information

Not Applicable.

Item 6    Exhibits

See Index to Exhibits immediately following this page.
38

INDEX TO EXHIBITS

  Incorporated by Reference
Exhibit
Number		Exhibit DescriptionFormFile No.Exhibit (s)Filing Date
Amended and Restated Articles of Incorporation of Mannatech, Incorporated, dated May 19, 1998.
S-1333-631333.1September 10, 1998
Amendment to the Amended and Restated Articles of Incorporation of Mannatech, dated January 13, 2012.8-K000-246573.1January 17, 2012
Fifth Amended and Restated Bylaws of Mannatech, dated August 25, 2014.8-K000-246573.1August 27, 2014
Specimen Certificate representing Mannatech’s common stock, par value $0.0001 per share.S-1333-631334.1October 28, 1998
Loan Agreement and Promissory Note with Jade Capital, signed April 23, 2024.8-K000-2465710.2April 23, 2024
Loan Agreement and Promissory Note with J. Stanley Fredrick, signed April 23, 2024.8-K000-2465710.2April 23, 2024
    
Loan Agreement and Promissory Note with Kevin Robbins, signed April 23, 2024.		8-K000-2465710.2April 23, 2024
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, of the Chief Executive Officer of Mannatech.****
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, of the Chief Financial Officer of Mannatech.****
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of the Chief Executive Officer of Mannatech.********
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of the Chief Financial Officer of Mannatech.********
101.INS*XBRL Instance Document****
101.SCH*XBRL Taxonomy Extension Schema Document****
101.CAL*XBRL Taxonomy Extension Calculation Linkbase Document****
101.LAB*XBRL Taxonomy Extension Label Linkbase Document****
101.PRE*XBRL Taxonomy Extension Presentation Linkbase Document****
101.DEF*XBRL Taxonomy Extension Definition Linkbase Document****

*Filed herewith.
**Furnished herewith.
39

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 MANNATECH, INCORPORATED
  
Dated: November 12, 2024By:/s/ Landen Fredrick
Landen Fredrick
  Chief Executive Officer
  (principal executive officer)
Dated: November 12, 2024By:/s/ James Clavijo
  James Clavijo
  Chief Financial Officer
  (principal financial officer)

40

Exhibit 31.1

CERTIFICATION
PURSUANT TO 17 CFR 240.13a-14
PROMULGATED UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Landen Fredrick, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Mannatech, Incorporated;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, which involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: November 12, 2024
/s/ Landen Fredrick
Landen Fredrick
Chief Executive Officer
(principal executive officer)
41

Exhibit 31.2

CERTIFICATION
PURSUANT TO 17 CFR 240.13a-14
PROMULGATED UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James Clavijo, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Mannatech, Incorporated;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, which involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: November 12, 2024
/s/ James Clavijo
James Clavijo
Chief Financial Officer
(principal financial officer)
42

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Mannatech, Incorporated (the “Company”) on Form 10-Q for the period ending September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Landen Fredrick, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 12, 2024
/s/ Landen Fredrick
Landen Fredrick
Chief Executive Officer
(principal executive officer)

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN PROVIDED TO MANNATECH, INCORPORATED AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.

43

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Mannatech, Incorporated (the “Company”) on Form 10-Q for the period ending September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James Clavijo, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 12, 2024
/s/ James Clavijo
James Clavijo
Chief Financial Officer
(principal financial officer)

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN PROVIDED TO MANNATECH, INCORPORATED AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.


44